525
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer

, , , & ORCID Icon
Pages 971-981 | Received 10 Jul 2020, Accepted 02 Sep 2020, Published online: 21 Sep 2020
 

Abstract

Peroxisome Proliferator-Activated Receptors-γ (PPAR-γ), a ligand-activated transcription factor, suggested having anti-inflammatory effects by activating the target genes when bound to the ligand. Herein, we examined a conformational analysis of 8708 derivatives of Kaempferol, Quercetin, and Resveratrol, the prime activators of PPAR-γ molecular target by employing molecular docking and dynamic simulation pipeline to screen out potential agonists. The structure-based docking procedure performed by FlexX tool shortlisted high binding affinities of these derivatives of Kaempferol, Quercetin and Resveratrol with the protein receptor with a score of −38.94 kcal/mol (4'-Carboxy-5, 7-Dihydroxyflavone-CDHF), −41.63 kcal/mol (Demethyltorosaflavone D- DMTF) and −31.52 kcal/mol (Resveratrol-O-disulphate- RD) respectively, signifying the selected derivatives forms interactions like H-bond, Aromatic H-Bond, Pi-Pi stacking and salt bridges with PPAR-γ. The PPAR-γ-derivative complex was stabilized by intermolecular hydrogen bonds and stacking interactions. A greater interaction was significantly observed between the binding affinities of derivatives compared to the standards. Based on the root mean square deviation (RMSD) and root mean square fluctuation (RMSF) carried by the means of high-speed molecular dynamics (MD) and simulation of best-docked poses, the ligand, DMTF attained the most favored interaction with PPAR-γ. Thus, it appeared to have high chemical scaffold diversity and may confer high drug-likeness. The binding free energy (ΔG) led us to manifest Quercetin derivative to have a key role for PPAR-γ receptor. The result obtained clearly indicates the exploitation of the promising new drug leads that may further influence in synthesizing and analyzing the development as anti-cancer agonists.

Communicated by Ramaswamy H. Sarma

Acknowledgements

The authors are thankful to Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune for the physical infrastructure and Department of Science and Technology Science and Engineering Research Board (DST-SERB), Govt. of India, New Delhi, (File Number: ECR/2016/000943) for financial support and S. Ballav is thankful to DST-SERB for Junior Research Fellowship.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

Authors also acknowledge the support of DST-SERB, Govt. of India, New Delhi, for utilizing an optimized supercomputer for docking and dynamics calculations (File Number: YSS/2015/002035). Senior Research Fellowship awarded to K. B. Lokhande (Project ID: 2019-3458; File No.: ISRM/11(54)/2019) of the Indian Council of Medical Research, New Delhi is also acknowledged.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,074.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.